Salix Pharmaceuticals Ltd. (SLXP) Stock Quote

Detailed Quote for Salix Pharmaceuticals Ltd. (SLXP)

After Hours: $ 48.18

0.00 (0.00%)

Volume: 839

4:50 PM EST Feb 10, 2012

close 52 Week Information

52 Week High

January 17, 2012

Close: 50.28

52 Week Low

September 22, 2011

Close: 25.64

Today

Last Price
48.18

Change $
0.71

Change %
1.45%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
48.63

High
48.71

Low
44.52

Prev Close
48.89

Last Trade
2/10/12

Volume
3.48 m

52 Wk Hi
50.28

52 Wk Low
25.64

Market Cap
2.85 b

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
59,134,581

EPS (TTM)
1.33

PE Ratio
36.20

close Exchange Information Listed On Nasdaq Global Select (NGS) Exchange
NGS

News and Media for Salix Pharmaceuticals Ltd. (SLXP)

Sector News | Topic News

News for SLXP

Tue, Feb 07, 2012

7:00 AM

Salix Pharmaceuticals Announces FDA Granting of Priority Review Designation for the Crofelemer NDA for Treatment of Diarrhea in Patients with HIV/AIDS on Anti-Retroviral Therapy - Business Wire

Wed, Jan 04, 2012

10:00 AM

Salix Pharmaceuticals to Present at J.P. Morgan Healthcare Conference - Business Wire

Tue, Dec 20, 2011

2:00 PM

Salix Pharmaceuticals Completes Acquisition of Oceana Therapeutics - Business Wire

7:00 AM

Salix and Progenics Announce Positive Highly Statistically Significant Results of Oral Methylnaltrexone for Phase 3 Trial in Chronic, Non-Cancer Pain Subjects with Opioid-Induced Constipation - Business Wire

Wed, Dec 14, 2011

7:00 AM

Salix Pharmaceuticals Announces NDA Submission for Crofelemer for the Treatment of HIV-Associated Diarrhea - Business Wire

Tue, Nov 29, 2011

7:00 AM

Salix Pharmaceuticals to Present at Oppenheimer Healthcare Conference - Business Wire

Wed, Nov 16, 2011

6:02 PM

FDA Advisory Committee Supports Proposed Clinical Trial Design to Evaluate Repeat Treatment Cycles of XIFAXAN® for Irritable Bowel Syndrome with Diarrhea - Business Wire

Mon, May 02, 2011

8:53 AM

Equity Research on Salix Pharmaceuticals Ltd. and Mylan Inc. -- Generic Drugs Gaining Ground - Marketwire

More News for SLXP >>

Tags for Salix Pharmaceuticals Ltd.

Research stocks or mutual funds related to Salix Pharmaceuticals Ltd. by keywords or tags. Find companies that have a similar focus to SLXP. The keywords below have been associated to SLXP by either user submission or electronic means.

biotechnology company pharmaceuticals research pharmaceutical branding pharmaceutical industry strategy pharmaceutical market pharmaceuticals companies generic pharmaceutical pharmaceuticals logistics biotechnology market pharmaceutical research and development pharmaceutical manufacturing company pharma marketing pharmaceutical industry marketing xifaxan pharmaceutical software pfizer pharmaceutical company pharmaceuticals supply chain pharma companies pharma consulting pharmaceutical sales pharma pharmaceutical distributors pharmaceutical development pharmaceutical sales rep pharmaceutical reports biotech Drugs veterinary pharmaceuticals pharmaceutical industry news pharmaceutical manufacturing software requip side effects pharmaceutical manufacturing contract pharmaceutical pharmaceutical consulting pharmaceutical industry pharmacy companies pharmaceutical studies pharmaceutical strategy side effects of edta pharmaceutical advances loratadine side effects pharmaceutical distributor pharmaceutical jobs pharmaceutical out licensing pharmaceutical business development trasylol side effects Gastroenterologist Healthcare bio pharmaceuticals jobs in pharmaceuticals